pfizer glp-1 agonist glp 1 While Lilly and Novo dominate today's $50B+ obesity market, is preparing a killer portfolio to steal the spotlight in 2030s glp1 #type2diabetes #preclinicalmodels Pfizer pulls out of GLP-1

I would buy it myself when my bottle is empty

Quick Stats of the GLP-1 Nutritional Support Market Industry Value (2025): USD 4.1 billion Forecast Value (2035): USD 13 billion Global CAGR (2025 to 2035): 12.2% Leading Segment in 2025: Protein & Macronutrient Blends (~43% share) Key Growth Region: East Asia Key Players: Nestl Health Science, Abbott, Herbalife, Unjury Protein, ProCare Health, Expansion is being shaped by clinical treatment protocols and broader reimbursement for weight loss and metabolic support

By showing a variety of results, patients are more likely to remain engaged and consistent with their treatment plans, leading to higher long-term satisfaction

I had a damaged pack where 3 cells came down to 3.9 or so, and the last cell was not being drained at all

Immune or gut health improvements often take 2-6 weeks